Nalox-1 Pharmaceuticals, LLC et al. vs. Opiant Pharmaceuticals, Inc.
Explore the PTAB proceeding IPR2019-00694 filed by Nalox-1 Pharmaceuticals, LLC et al. on 2019-02-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2019-00694
Filing Date
2019-02-19
Accorded Filing Date
2019-02-19
Institution Decision Date
2019-09-11
Last Modified Date
β
Proceeding Type
IPR
Termination Date
2020-08-21
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Nalox-1 Pharmaceuticals, LLC et al.
Represented By
Kim, Yeleeet alPatent Owner / Respondent
Opiant Pharmaceuticals, Inc.
Represented By
Berniker, Jessamyn S.et alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34547 | Dennis Bennett | +1 314-812-8018 |
| 36691 | Lauren Stevens | +1 224-500-9023 |
| 59735 | Cynthia Hathaway | +1 877-812-8020 |
| 65040 | Brock Levin | +1 913-787-3513 |
| 70629 | Robert Eisler | +1 805-223-0028 |
| 72123 | Stephanie Greer | +1 214-803-1130 |
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 9,629,965 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2017030429 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2021027551 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2014619533 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,211,253 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,480,644 B2 | US Continuation / Sibling | View Official Patent → |
Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.
Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.
Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.
Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.
Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.